This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

US states' opposition to Sandoz settlement shows no prejudice, Florida says

( March 31, 2025, 20:07 GMT | Official Statement) -- MLex Summary: Florida's attorney general told a US judge that 22 US states and territories' opposition to its settlement with Sandoz, Novartis and others doesn't reference any "plain legal prejudice," and that Florida alone has control over its claims. The states complaining about the settlement's most-favored-nation agreements ignore that members among them use the same MFN provisions and are merely "unhappy with their current bargaining positions after nearly a decade of litigation," the response brief filed to the District of Connecticut said. See attached document:...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections